Sling Therapeutics
Delivering New Therapies for Thyroid Eye Disease and Beyond
Ann Arbor, United States · $35.0M raised
- Headquarters
- Ann Arbor
- Business Model
- B2B
- Website
- slingtx.com
- Total Funding
- $35.0M
- Last Round
- $35.0M Series AJun 2022
- Rounds
- 1
About
Sling Therapeutics is a biopharmaceutical company focused on late-stage development for thyroid eye disease, aspiring to improve the lives of patients and their families. Its experienced executives, drug developers, and scientific advisors work urgently to develop additional therapies while upholding high quality standards.
Summary
Sling Therapeutics is a Biotech company based in Ann Arbor, United States. It has raised $35.0M in total across 1 round, most recently a $35.0M Series A round in Jun 2022. Investors include The Rise Fund and TPG (Growth/Rise).
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2022
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sling-therapeutics"><img src="https://indexed.vc/api/badge/company/sling-therapeutics" alt="Sling Therapeutics on Indexed.vc" width="260" height="76" /></a>